Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The importance of stress as a possible deteriorating factor for schizophrenic patients is well documented. However, this notion is based on subjective experience and retrospective psychological analysis.
A novel method of measuring cortisol using hair has a proven correlation to subjective stress in non-clinical as well as psychiatric clinical populations.
This pilot study will attempt to assess the use of cortisol hair level, as a marker of stress, to predict clinical deterioration in schizophrenic patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Schizophrenia patients |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hair Sample | Biological | Analysis of hair cortisol levels |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in Positive And Negative Symptoms Score | correlation between hair cortisol level change from baseline and PANSS score change from baseline. | 3 month |
| Change from Baseline in Positive And Negative Symptoms Score | correlation between hair cortisol level change from baseline and PANSS score change from baseline. | 6 month |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in SANS, CGI, CDS, GAF and QOL Scores | correlation between hair cortisol level change from baseline and SANS, CDS, GAF, CGI, and QOL scores change from baseline. | 3 month |
| Change from Baseline in SANS, CGI, CDS, GAF and QOL Scores |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients diagnosed with Schizophrenia or Schizo-Affective Disorder
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Aviv Segev, MD | Shalvata MHC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shalvata MHC | Hod HaSharon | Israel |
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| D011618 | Psychotic Disorders |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
10mg of posterior vertex hair
correlation between hair cortisol level change from baseline and SANS, CDS, GAF, CGI, and QOL scores change from baseline. |
| 6 month |